drugset / Trial / NCT00094991

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

NCT00094991

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to learn more about how muraglitazar lowers blood sugar in people with type 2 diabetes. The safety of this treatment will also be studied.

Timeline

Start
2004-05
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Muraglitazar Small molecule